Taub R N, Roncari D A, Baker M A
Cancer Res. 1978 Dec;38(12):4624-9.
Peripheral blood myeloblasts from five patients with acute myeloblastic leukemia and peripheral remission leukocytes from two of these patients were radiolabeled by the lactoperoxidase-catalyzed surface radioiodination technique and incubated in a nutrient medium at 37 degrees. Radioactive materials shed from viable cells into the supernatant at 24 hr were purified by gel filtration and by DEAE-cellulose chromatography. The radiolabeled leukemic cells shed relatively few molecular species into the culture medium. The DEAE-cellulose eluate usually contained one major peak in which radioactivity and protein levels were coincident; the molecular weight of this compound was 350,000 to 400,000, and it contained carbohydrate as well as protein. Glycoprotein shed from leukemic cells was specifically reactive in a coprecipitation assay with defined antimyeloblast alloantisera obtained from leukemic patients receiving immunotherapy. No reaction was seen with antisera directed against HLA or B-cell antigens. Material shed from remission cells did not coprecipitate with antileukemic antisera. The isolation of radioactively labeled antigen derived from myeloblasts may ultimately allow the monitoring of human antigen levels in leukemic blood by radioimmunoassay.
采用乳过氧化物酶催化的表面放射性碘化技术,对5例急性髓细胞白血病患者的外周血成髓细胞以及其中2例患者外周血缓解期白细胞进行放射性标记,并于37℃在营养培养基中孵育。24小时时从活细胞释放到上清液中的放射性物质通过凝胶过滤和DEAE-纤维素色谱法进行纯化。放射性标记的白血病细胞向培养基中释放的分子种类相对较少。DEAE-纤维素洗脱液通常含有一个主要峰,其中放射性和蛋白质水平一致;该化合物的分子量为350,000至400,000,它含有碳水化合物以及蛋白质。白血病细胞释放的糖蛋白在与接受免疫治疗的白血病患者获得的特定抗成髓细胞同种抗血清的共沉淀试验中具有特异性反应。针对HLA或B细胞抗原的抗血清未见反应。缓解期细胞释放的物质不与抗白血病抗血清共沉淀。从成髓细胞衍生的放射性标记抗原的分离最终可能允许通过放射免疫测定监测白血病血液中的人类抗原水平。